CD133-positive cells from non-small cell lung cancer show distinct sensitivity to cisplatin and afatinib

• Autorzy: Alama A. , Gangemi R. , Ferrini S. , Barisione G. , Orengo A.M. , Truini M. , Bello M.G.D. , Grossi F.
• Języki publikacji: EN

Abstrakty

EN

Słowa kluczowe

EN

cisplatin; non-small cell lung cancer; afatinib; chemotherapy; epidermal growth factor receptor; tyrosine kinase; CD133 positive cell; drug resistance; patient

• Wydawca: -
• Czasopismo: Archivum Immunologiae et Therapiae Experimentalis
• Rocznik: 2015
• Tom: 63
• Numer: 3
• Opis fizyczny: p.207-214,fig.,ref.

Twórcy

autor

Alama A.

• Lung Cancer Unit, IRCCS A.O.U. San Martino-IST, National Institute for Cancer Research, Largo Rosanna Benzi, 10, 16132 Genoa, Italy

autor

Gangemi R.

• Laboratory of Bio-therapy, IRCCS A.O.U. San Martino-IST, National Institute for Cancer Research, Largo Rosanna Benzi, 10, 16132 Genoa, Italy

autor

Ferrini S.

• Laboratory of Bio-therapy, IRCCS A.O.U. San Martino-IST, National Institute for Cancer Research, Largo Rosanna Benzi, 10, 16132 Genoa, Italy

autor

Barisione G.

• Laboratory of Bio-therapy, IRCCS A.O.U. San Martino-IST, National Institute for Cancer Research, Largo Rosanna Benzi, 10, 16132 Genoa, Italy

autor

Orengo A.M.

• Laboratory of Bio-therapy, IRCCS A.O.U. San Martino-IST, National Institute for Cancer Research, Largo Rosanna Benzi, 10, 16132 Genoa, Italy

autor

Truini M.

• Department of Pathology, IRCCS A.O.U. San Martino-IST, National Institute for Cancer Research, Largo Rosanna Benzi, 10, 16132 Genoa, Italy

autor

Bello M.G.D.

• Lung Cancer Unit, IRCCS A.O.U. San Martino-IST, National Institute for Cancer Research, Largo Rosanna Benzi, 10, 16132 Genoa, Italy

autor

Grossi F.

• Lung Cancer Unit, IRCCS A.O.U. San Martino-IST, National Institute for Cancer Research, Largo Rosanna Benzi, 10, 16132 Genoa, Italy

Identyfikatory

DOI

10.1007/s00005-015-0330-5